Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

688065.SS

SELLFLAG

Cathay Biotech Inc. · Basic Materials · China · $4.3B · Avg Vol: $41M/d

27
StockRank
Q
55
V
26
M
38
P/E (TTM)
54.8x
ROE
2.7%
D/E
0.1x
Dividend %
1.0%
AI CONVICTION THESIS

Cathay Biotech is a synthetic biology leader producing bio-based nylon with high quality metrics (Q: 55). It benefits from localization of green chemical supply chains, but near-term overcapacity in the Chinese chemical sector limits immediate upside.

COMPANY DESCRIPTION

Cathay Biotech Inc. produces bio-based materials, including long-chain dicarboxylic acids (LCDA), bio-based diamines, and bio-based polyamides. The company is the global leader in bio-synthetic LCDA, holding a near-monopoly market share through proprietary metabolic engineering and fermentation technologies. It is a pioneer in industrial biotechnology, replacing fossil-fuel-derived plastics with sustainable, high-performance bio-materials.

FINANCIAL SUMMARY (USD)

Year2022202320242025CAGR
Revenue361M312M437M487M10.5%
EPS0.140.090.120.12-4.8%
Shares583M583M583M721M+23.7%
Debt167M262M280M74M-23.6%
Equity1.6B1.6B1.7B2.6B17.4%
Op CF119M84M121M60M-20.5%
Inv CF-620M-230M-122M-107M
Fin CF60M-39M22M638M
Loading...
PRICE (1M)-6.5%
5.916.206.496.787.06May 8May 29Jun 18
SMA 50SMA 200
Close
$6.58
RSI (14)
69.2
52W High
$9.53
From 52W High
0.7%

SCORE BREAKDOWN

Quality
55
ROIC
2.9%46.5
ROE
2.7%45.9
GP/Assets
4.4%22.7
Op. Margin
24.4%85.7
FCF/Assets
-2.9%40.5
Piotroski
51.5
Int. Cover
50.0x93.3
D/E Ratio
0.05x76.3
Current Ratio
5.11x79.7
Value
26
P/E (TTM)
54.8x19.4
EV/EBITDA
30.8x11.0
P/FCF
N/A
P/B
1.8x52.8
P/S
9.6x15.2
Div Yield
1.0%34.9
Momentum
38
52W High %
69%43.0
RS 6M
-12%43.6
SMA 50/200
0.91x16.6
EPS Rev 4W
N/A
EPS Rev 12W
N/A
EPS Improve
+48%39.5
Q Growth
21%47.7

FUNDAMENTALS

Market Cap
$4.3B
P/E (Forward)
37.1x
Gross Margin
30.8%

SECTOR PEERS

Closest peers in Basic Materials, ranked by industry match, size, and score similarity. Cross-listings of 688065.SS are excluded.

TickerCompanyMkt CapStockRankSignal
688065.SSCathay Biotech Inc.(you)$4.3B27SELL
000973.SZFSPG Hi-Tech CO., Ltd.$5.4B31SELL
603077.SSSichuan Hebang Biotechnology Corporation Limited$3.2B31SELL
603002.SSEpoxy Base Electronic Material Corporation Limited$2.8B26SELL
003022.SZLevima Advanced Materials Corporation$4.9B35HOLD
002407.SZDo-Fluoride New Materials Co., Ltd.$5.9B32SELL
300769.SZShenzhen Dynanonic Co., Ltd$2.7B25SELL
002145.SZTinergy Chemical Co., Ltd.$2.4B29SELL
300568.SZShenzhen Senior Technology Material Co., Ltd.$3.1B20SELL
600589.SSDawei Technology (Guangdong) Group Co., Ltd.$2.4B25SELL

Peer medians: ROE 6.2% · P/E 33.1x · Gross margin 17.5%

Cathay Biotech Inc. (688065.SS) — Stock Score Summary

Cathay Biotech Inc. (688065.SS) has a MoatMap StockRank of 27/100 based on Quality (55/100), Value (26/100), and Momentum (38/100) factor scores. The current signal is SELL. Cathay Biotech is a synthetic biology leader producing bio-based nylon with high quality metrics (Q: 55). It benefits from localization of green chemical supply chains, but near-term overcapacity in the Chinese chemical sector limits immediate upside.

Cathay Biotech Inc. produces bio-based materials, including long-chain dicarboxylic acids (LCDA), bio-based diamines, and bio-based polyamides. The company is the global leader in bio-synthetic LCDA, holding a near-monopoly market share through proprietary metabolic engineering and fermentation technologies. It is a pioneer in industrial biotechnology, replacing fossil-fuel-derived plastics with sustainable, high-performance bio-materials.

Key Financial Metrics

Price$6.58
Market Cap$4.3B
P/E (TTM)54.82
P/E (Forward)37.15
Price/Book1.81
Return on Equity2.7%
Return on Invested Capital2.9%
Debt/Equity5.09
Gross Margin30.8%
Operating Margin24.4%
Revenue Growth12.7%
Dividend Yield1.0%
Free Cash Flow$-15M

Cathay Biotech Inc. operates in the Chemicals industry, part of the Basic Materials sector (China).

Frequently Asked Questions

What is Cathay Biotech Inc.’s (688065.SS) StockRank?
MoatMap’s StockRank for Cathay Biotech Inc. (688065.SS) is 27/100, with a Sell signal. It is a composite of Quality (55), Value (26), and Momentum (38) factor ranks across MoatMap’s 20,000+ stock universe.
Does Cathay Biotech Inc. have an economic moat?
Cathay Biotech Inc. (688065.SS) has a Quality factor score of 55/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Cathay Biotech Inc. a buy, hold, or sell?
MoatMap’s current signal for Cathay Biotech Inc. (688065.SS) is Sell, based on a StockRank of 27/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Cathay Biotech Inc. in?
Cathay Biotech Inc. (688065.SS) operates in the Basic Materials sector, specifically the Chemicals industry (China).